Priority 22 from the Cavernoma PSP
| UNCERTAINTY: Which brain or spine cavernoma sites carry the highest risk of symptoms that impact on the life of patients? (JLA PSP Priority 22) | |
|---|---|
| Overall ranking | 22 |
| JLA question ID | 0035/22 |
| Explanatory note | Not available for this PSP |
| Evidence |
None available |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Not available |
| Comparison | Aetiology; Prognosis |
| Submitted by | 5 patients, 3 carers |
| Outcomes to be measured | Adverse effects or complications; health related quality of life |
| PSP information | |
|---|---|
| PSP unique ID | 0035 |
| PSP name | Cavernoma |
| Total number of uncertainties identified by this PSP. | 54 |
| Date of priority setting workshop | 23 September 2015 |